The intraoperative neuromonitoring market is expected to advance at a rate of 4.8%, to reach USD 4.93 billion by 2030 as per a report by P&S Intelligence.
 |
| Get the sample pages of this report: https://bit.ly/3AIr9zo |
This growth is credited to the increasing incidence of various lifestyles-related diseases, the rising demand for advanced intraoperative neuromonitoring and minimally invasive devices, and the growing focus on the safety of the patient during complex surgeries.
Insourced monitoring dominated the market, with approximately 52% revenue share, in recent years and it will remain dominant in the years to come. This is because of the rising demand for consistent monitoring, increasing acquisitions by device manufacturers, and growing number of surgical cases.
North American intraoperative neuromonitoring market held the largest revenue share, of approximately 51%, and it will remain dominant in the future. This is credited to the rising rate of IONM adoption, the advantageous reimbursement framework for such neuromonitoring solutions, the growing consciousness for neurological monitoring, the high incidence of neurological disorders, and the existence of developed healthcare infrastructure.
APAC will witness the fastest growth in the coming years. This is attributed to the increasing elderly population, the large number of healthcare reforms, the increasing incidence of chronic disorders, and the growing demand for advanced healthcare services in China and India.
Due to the increasing technological advancement, and increasing research and development expenditures, the intraoperative neuromonitoring industry will grow substantially in the coming years.
No comments:
Post a Comment